Skip to main content
Fig. 5 | Molecular Cancer

Fig. 5

From: Metal-enriched HSP90 nanoinhibitor overcomes heat resistance in hyperthermic intraperitoneal chemotherapy used for peritoneal metastases

Fig. 5

The biodistribution of the nanoinhibitor in tumor-bearing mice. Images of bioluminescence (Luc) for tumor and fluorescence (Fluo) for DiR in CT26-Luc tumor-bearing mice after intraperitoneal treatment with (A) nanoinhibitor-DiR, (C) free DiR at different time points. Images of bioluminescence (Luc) and fluorescence (Fluo) for tumors and main organs in (B) nanoinhibitor-DiR group, (D) free DiR group at 168 h intraperitoneal injection. E, F The quantitative fluorescence analyses of tumors and major organs in the two groups of mice at 72 h and 168 h intraperitoneal injection, respectively. Tu, tumor. Ki, kidney. Lu, lung. Sp, spleen. Li, liver. He, heart. Avg, average. *p < 0.05 and **p < 0.01

Back to article page

Molecular Cancer

ISSN: 1476-4598